EX-99 5 table.txt EXH. 99.2, CONSOLIDATING BALANCE SHEETS Exhibit 99.2 MSCP HOLDINGS, INC. & AFFILIATES CONSOLIDATING BALANCE SHEET January 31, 2003 [in thousands]
MEDICALOGIC/ MSCP MEDICALOGIC MEDSCAPE, HOLDINGS, ENTERPRISES, INC. INC. INC. Assets Current assets: Cash and cash equivalents ...................... $ (30) $ --- $ --- Short-term investments ......................... 43,614 --- --- Accounts receivable, net ....................... --- --- --- Prepaid and other current assets ............... 1,025 --- --- Total current assets ........................ 44,609 --- --- Property and equipment, net ....................... --- --- --- Goodwill and intangible assets, net ............... --- --- --- Long-term investment and other assets, net ........ 320 320 --- Total assets ...................................... $ 44,929 $ 320 $ --- MEDICALOGIC MEDICALOGIC MEDICALOGIC ELIMINATING PENNSLYVANIA, OF TEXAS, TEXAS, LP ENTRIES CONSOLIDATED Assets LLC INC. Current assets: Cash and cash equivalents ...................... $ --- $ --- $ --- $ --- $ (30) Short-term investments ......................... --- --- --- --- 43,614 Accounts receivable, net ....................... --- --- --- --- Prepaid and other current assets ............... --- --- --- --- 1,025 Total current assets ........................ --- --- --- --- 44,609 Property and equipment, net ....................... --- --- --- --- --- Goodwill and intangible assets, net ............... --- --- --- --- --- Long-term investment and other assets, net ........ --- --- --- (320) 320 Total assets ...................................... $ --- $ --- $ --- $ (320) $ 44,929
Liabilities and shareholders' equity MEDICALOGIC MSCP MEDICALOGICE MEDSCAPE, INC. HOLDINGS, INC. ENTERPRISES, INC. Current liabilities: Accounts payable ............................... $ 236 $ --- $ --- Accrued and other liabilities .................. 2,787 --- --- Deferred revenue ............................... --- --- --- Long-term liabilities, current portion ......... --- --- --- Other current liabilities ........................ --- --- --- Total current liabilities ................... 3,023 --- --- Long-term liabilities, net of current portion ..... --- --- --- Long-term deferred revenue, net of current portion --- --- --- Other long-term liabilities ....................... --- --- --- Total liabilities ........................... 3,023 --- --- Convertible redeemable series A preferred stock ... 19,626 --- --- Shareholders' equity: Common stock ................................... 1,255,103 728,916 --- Common stock notes receivable, net ............. (439) --- --- Warrants ....................................... 52,077 --- --- Deferred stock compensation .................... --- --- --- Accumulated deficit ............................ (1,284,461) (728,596) --- Total shareholders' equity .................. 22,280 320 --- Total liabilities and shareholder's equity $ 44,929 $ 320 $ --- Liabilities and shareholders' equity MEDICALOGIC MEDICALOGIC MEDICALOGIC ELIMINATING PENNSYLVANIA, OF TEXAS, TEXAS, LP ENTRIES CONSOLIDATED LLC INC. Current liabilities: Accounts payable ............................... $ --- $ --- $ --- $ --- $ 236 Accrued and other liabilities .................. --- --- --- --- 2,787 Deferred revenue ............................... --- --- --- --- --- Long-term liabilities, current portion ......... --- --- --- --- --- Other current liabilities ........................ --- --- --- --- --- Total current liabilities ................... --- --- --- --- 3,023 Long-term liabilities, net of current portion ..... --- --- --- --- --- Long-term deferred revenue, net of current portion --- --- --- --- --- Other long-term liabilities ....................... --- --- --- --- --- Total liabilities ........................... --- --- --- --- 3,023 Convertible redeemable series A preferred stock ... --- --- --- --- 19,626 Shareholders' equity: Common stock ................................... --- --- --- (728,916) 1,255,103 Common stock notes receivable, net ............. --- --- --- --- (439) Warrants ....................................... --- --- --- --- 52,077 Deferred stock compensation .................... --- --- --- --- --- Accumulated deficit ............................ --- --- --- 728,596 (1,284,461) Total shareholders' equity .................. --- --- --- (320) 22,280 Total liabilities and shareholder's equity $ --- $ --- $ --- $ (320) $ 44,929 --- --- --- ---
The accompanying unaudited special purpose financial information was prepared for the purpose of complying with the reporting requirements of the Office of the United States Trustee and are not intended to be a presentation in conformity with accounting principles generally accepted in the United States.